Topical Treatment With Bromfenac Reduces Retinal Gliosis and Inflammation After Optic Nerve Crush | Zendy

Giuseppe Rovere | Zendy; Francisco M. NadalNicolás | Zendy; Paloma SobradoCalvo | Zendy; David GarcíaBernal | Zendy; María Paz VillegasPérez | Zendy; Manuel VidalSanz | Zendy; Marta AgudoBarriuso | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Topical Treatment With Bromfenac Reduces Retinal Gliosis and Inflammation After Optic Nerve Crush

Author(s) -

Giuseppe Rovere,

Francisco M. NadalNicolás,

Paloma SobradoCalvo,

David GarcíaBernal,

María Paz VillegasPérez,

Manuel VidalSanz,

Marta AgudoBarriuso

Publication year - 2016

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.16-20425

Subject(s) - gliosis , retinal , glial fibrillary acidic protein , medicine , retina , optic nerve , ophthalmology , vimentin , intravitreal administration , nerve fiber layer , pharmacology , pathology , immunohistochemistry , biology , neuroscience

To study the effect of topical administration of bromfenac, a nonsteroidal anti-inflammatory drug (NSAID), on retinal gliosis and levels of prostaglandin E2 (PGE2) after complete optic nerve crush (ONC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research